Quarterly report pursuant to Section 13 or 15(d)

Schedule of Discontinued Operation of Balance Sheet and Operation Statement (Details)

v3.21.2
Schedule of Discontinued Operation of Balance Sheet and Operation Statement (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Cash     $ 31,430
Accounts receivable, net     151,363
Prepaid expenses and other current assets     1,717
Current assets classified as held for sale     184,510
Property and equipment, net     685
Deposits 5,014   5,014   100,014
Right of use assets     100,116
Non-current assets classified as held for sale 5,014   5,014   200,815
Accounts payable and checks issued in excess of bank balance 1,111,557   1,111,557   1,911,378
Accrued expenses 336,410   336,410   1,642,950
Current portion of right-of-use operating lease obligation     91,166
Current portion of notes payable     168,751
Current liabilities classified as held for sale 1,447,967   1,447,967   3,814,245
Note payable     69,267
Right-of-use operating lease obligation     8,950
Liabilities classified as held for sale     78,217
Revenue from services   $ 174,941 216,941 $ 437,560  
Cost of services   390 2,386 11,379  
Gross profit   174,551 214,555 426,181  
Operating expenses (31,388) (300,149) (677,539) (616,693)  
Other income (expense)   (40,582) 39,193 26,219  
Gain on sale 576,787 11,303,939  
Provision for income taxes  
Income (loss) from discontinued operations 545,399 (166,180) 10,880,148 (164,293)  
Advanced Molecular Services Group And Health Technology Solutions Inc [Member]          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Cash     31,294
Accounts receivable, net     151,363
Prepaid expenses and other current assets     1,717
Current assets classified as held for sale     184,374
Property and equipment, net     685
Deposits    
Right of use assets    
Non-current assets classified as held for sale     685
Accounts payable and checks issued in excess of bank balance     726,220
Accrued expenses     1,308,283
Current portion of right-of-use operating lease obligation    
Current portion of notes payable     168,751
Current liabilities classified as held for sale     2,203,254
Note payable     69,267
Right-of-use operating lease obligation    
Liabilities classified as held for sale     69,267
Revenue from services 174,941 216,941 437,119  
Cost of services 390 2,386 11,379  
Gross profit 174,551 214,555 425,740  
Operating expenses (258,710) (551,296) (509,989)  
Other income (expense) (9,636) (9,577) (61,067)  
Gain on sale 576,787 11,303,939  
Provision for income taxes  
Income (loss) from discontinued operations 576,787 (93,795) 10,957,621 (145,316)  
EPIC Reference Labs, Inc. [Member]          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Cash     136
Accounts receivable, net    
Prepaid expenses and other current assets    
Current assets classified as held for sale     136
Property and equipment, net    
Deposits 5,014   5,014   100,014
Right of use assets     100,116
Non-current assets classified as held for sale 5,014   5,014   200,130
Accounts payable and checks issued in excess of bank balance 1,111,557   1,111,557   1,185,158
Accrued expenses 336,410   336,410   334,667
Current portion of right-of-use operating lease obligation     91,166
Current portion of notes payable    
Current liabilities classified as held for sale 1,447,967   1,447,967   1,610,991
Note payable    
Right-of-use operating lease obligation     8,950
Liabilities classified as held for sale     $ 8,950
Revenue from services 441  
Cost of services  
Gross profit   441  
Operating expenses (31,388) (41,439) (126,243) (106,704)  
Other income (expense)   (30,946) 48,770 87,286  
Gain on sale  
Provision for income taxes  
Income (loss) from discontinued operations $ (31,388) $ (72,385) $ (77,473) $ (18,977)